SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2.

The Orioles today announced the club’s 2025 Opening Day roster. The 26-man roster includes: Seven players will start on the ...

They received a silver award for Innovation in Debridement at the Journey of Wound Care Awards, held at the Imperial War Museum in London. Their work, alongside surgical colleagues, has also seen ...

Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcers SOLASCURE Ltd (SolasCure), a biotechnology company ...